Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/50807
Title: Use of intravenous cyclophosphamide in vasculitis patients : adherence to local pharmacotherapy management guidelines
Authors: Grech, Louise
Zammit Dimech, David
Cassar, Kathlene
Aquilina, Doris
Keywords: Vasculitis -- Chemotherapy -- Malta -- Case studies
Vasculitis -- Patients -- Care
Cyclophosphamide
Pharmacist and patient
Patient compliance
Issue Date: 2016-04
Publisher: University of Malta. Department of Pharmacy
Citation: Grech, L., Zammit Dimech, D., Cassar, K., & Aquilina, D. (2016, April). Use of intravenous cyclophosphamide in vasculitis patients: adherence to local pharmacotherapy management guidelines. Poster session presented at the British Society for Rheumatology, Annual Conference, Glasgow, United Kingdom.
Abstract: A poster presentation regarding the use of intravenous cyclophosphamide in vasculitis patients and adherence to local pharmacotherapy management guidelines. Introduction: Intravenous (IV) cyclophosphamide is considered central in the pharmacotherapy management of vasculitis, which if untreated, could lead to multi-organ damage and untimely patients’ death. An evidenced-based shared care guideline (SCG) on the prescribing of IV cyclophosphamide in vasculitis patients is in use at Mater Dei Hospital, Malta. This guideline helps clinicians, pharmacists and nurses to work together as a team towards effective patient safety and increasing the quality of care service offered to patients. Aims: • To assess the clinical adherence to the shared care guideline on the pharmacotherapy management of intravenous cyclophosphamide in vasculitis patients. • To identify gaps in adherence against the shared care guideline.
URI: https://www.um.edu.mt/library/oar/handle/123456789/50807
Appears in Collections:Scholarly Works - FacM&SPha



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.